Hikari Araki

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Hikari Araki is an author at Taiho Pharmaceutical (Japan) specializing in therapeutic target identification, her2 gene amplification, and covalent drug binding.

ORCID

Publications per year

2019–2022

Publications

TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Hiroki Irie, Kimihiro Ito, Yayoi Fujioka et al. · Molecular Cancer Therapeutics · 2019 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

<scp>TAS2940</scp>, a novel <scp>brain‐penetrable pan‐ERBB</scp> inhibitor, for tumors with <i>HER2</i> and <i>EGFR</i> aberrations

Kei Oguchi, Hikari Araki, Shingo Tsuji et al. · Cancer Science · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacology +16

1–2 of 2